This statistic displays the median length of time that orphan and non-orphan products are in phase III trial, as of 2015. Orphan drugs were in phase III trials for a median of 2.89 years. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Median phase III trial length for orphan and non-orphan drugs as of 2015
(in years)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Evaluate. (October 30, 2015). Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years) [Graph]. In Statista. Retrieved May 19, 2022, from https://www.statista.com/statistics/373393/phase-iii-trial-length-for-orphan-and-non-orphan-drugs/
Evaluate. "Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years)." Chart. October 30, 2015. Statista. Accessed May 19, 2022. https://www.statista.com/statistics/373393/phase-iii-trial-length-for-orphan-and-non-orphan-drugs/
Evaluate. (2015). Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years). Statista. Statista Inc.. Accessed: May 19, 2022. https://www.statista.com/statistics/373393/phase-iii-trial-length-for-orphan-and-non-orphan-drugs/
Evaluate. "Median Phase Iii Trial Length for Orphan and Non-orphan Drugs as of 2015 (in Years)." Statista, Statista Inc., 30 Oct 2015, https://www.statista.com/statistics/373393/phase-iii-trial-length-for-orphan-and-non-orphan-drugs/
Evaluate, Median phase III trial length for orphan and non-orphan drugs as of 2015 (in years) Statista, https://www.statista.com/statistics/373393/phase-iii-trial-length-for-orphan-and-non-orphan-drugs/ (last visited May 19, 2022)
